Advertisement

Surgery pp 273-286 | Cite as

Nosocomial Infections

  • Pamela A. Lipsett

Abstract

Anosocomial infection (NI) is defined as an infection that is not present or incubating when the patient is admitted to a hospital or other health care facility.1 Generally, an infection that is discovered 48–72 h after admission is indicative of nosocomial, rather than community-acquired, infection. Although usually associated with hospital admission (hence the term hospital-acquired infection), Ms can arise after admission to any health care facility, and the term health care-associated infection is now preferred. Nosocomial infections are increasingly considered as a measure of quality of care and are the focus of safety and quality improvements efforts in many hospitals today.2, 3, 4, 5, 6, 7, 8 To date, the extent these NIs are avoidable under real-life hospital conditions and what represents the irreducible minimum remain unclear.9, 10, 11 A number of observational studies implementing multimodality strategies and standardized policies and practices have demonst rated a 10% to 70% reduction in infection rates depending on the setting, study design, type of infection, and baseline infection rates.9, 10, 11, 12, 13, 14, 15

Keywords

Nosocomial Infection Respir Crit Urinary Catheter Nosocomial Pneumonia National Nosocomial Infection Surveillance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Garner J, Jarvis W, Emori T, et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128–140.PubMedCrossRefGoogle Scholar
  2. 2.
    CDC. Public health focus: surveillance, prevention and control of nosocomial infections. MMWR Morb Mortal Wkly Rep 1992;41:783–787.Google Scholar
  3. 3.
    Vincent J. Nosocomial infections in the adult intensive care unit. Lancet 2003;361:2068–2077.PubMedCrossRefGoogle Scholar
  4. 4.
    Kohn L, Corrigan J, Donaldson M. To Err Is Human: Building a Safer Health System. Washington, DC: Institute of Medicine, National Academy Press, 1999.Google Scholar
  5. 5.
    Gaynes R, Solomon S. Improving hospital-acquired infection rates: the CDC experience. JCAHO J Quality Improvement 1996;22:457–467.Google Scholar
  6. 6.
    CDC. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1990–May 1999. Am J Infect Control 1999;27:520–532.CrossRefGoogle Scholar
  7. 7.
    Eggimann P, Pittet D. Infection control in the ICU. Chest 2001;120:2059–2093.PubMedCrossRefGoogle Scholar
  8. 8.
    Eggimann P, Sax H, Pittet D. Catheter-related infection. Microbes Infect 2004;6:1033–1042.PubMedCrossRefGoogle Scholar
  9. 9.
    Berenholtz S, Pronovost P, Lipsett P, et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 2004;32:2014–2020.PubMedCrossRefGoogle Scholar
  10. 10.
    National Center for Health Statistics. Healthy People 2000 Review 1998–1999. Hyattsville, MD: U.S. Department of Health and Human Services, CDC, 2000.Google Scholar
  11. 11.
    Culver D, White J, Morgan W, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in U.S. hospitals. Am J Epidemiol 1985;121:182–205.PubMedGoogle Scholar
  12. 12.
    Eggimann P, Harbarth S, Constantin M, et al. Impact of a prevention strategy targeted at vascular access care on incidence of infections acquired in intensive care. Lancet 2000;355:1864–1868.PubMedCrossRefGoogle Scholar
  13. 13.
    Hacek D, Suriano T, Noskin G, et al. Medical and economic benefit of a comprehensive infection control program that includes routine determination of microbial clonality. Am J Clin Pathol 1999;111:647–654.PubMedGoogle Scholar
  14. 14.
    Dumigan D, Kohan C, Reed C, et al. Utilizing national nosocomial infection surveillance system data to improve urinary tract infection rates in three intensive-care units. Clin Perform Qual Health Care 1998;6:172–178.PubMedGoogle Scholar
  15. 15.
    McConkey S, L’Ecuyer P, Murphy D, et al. Results of a comprehensive infection control program for reducing surgical-site infections in coronary artery bypass surgery. Infect Control Hosp Epidemiol 1999;8:533–538.CrossRefGoogle Scholar
  16. 16.
    NNIS System. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470–485.CrossRefGoogle Scholar
  17. 17.
    Saint S, Savel R, Matthay M. Enhancing the safety of critically ill patients by reducing urinary and central venous catheter-related infections. Am J Respir Crit Care Med 2002;165:1475–1479.PubMedCrossRefGoogle Scholar
  18. 18.
    Wenzel R, Edmond M. The impact of hospital-acquired bloodstream infections. Emerg Infect Dis 2001;7:174–177.PubMedCrossRefGoogle Scholar
  19. 19.
    U. S. Department of Health and Human Services. Healthy People 2010, U.S. Department of Health and Human Services, conference ed. Washington, DC: U.S. Department of Health and Human Services, 2000.Google Scholar
  20. 20.
    Monitoring hospital-acquired infections to promote patient safety-United States, 1990–1999. MMWR Morb Mortal Wkly Rep 2000;49:149–153.Google Scholar
  21. 21.
    Stone P, Larson E, Nijab Kawar L. A systematic audit of economic evidence linking nosocomial infections and infection control interventions: 1990–2000. Am J Infect Control 2002;30:145–152.PubMedCrossRefGoogle Scholar
  22. 22.
    Vincent J, Bihari D, Suter P, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) study. JAMA 1995;274:639–644.PubMedCrossRefGoogle Scholar
  23. 23.
    Döcke W, Randow F, Syrbe H, et al. Monocyte deactivation in septic patients: restoration by IFN-γ treatment. Nat Med 1997;3:678–681.PubMedCrossRefGoogle Scholar
  24. 24.
    Asadullah K, Woiciechowsky C, Docke W, et al. Immunodepression following neurosurgical procedures. Crit Care Med 1995;23:1976–1983.PubMedCrossRefGoogle Scholar
  25. 25.
    Schinkel C, Sendtner R, Zimmer S, et al. Functional analysis of monocyte subsets in surgical sepsis. J Trauma 1998;44:743–748.PubMedCrossRefGoogle Scholar
  26. 26.
    Peters M, Petros A, Dixon G, et al. Acquired immunoparalysis in paediatric intensive care: prospective observational study. BMJ 1999;319:609–610.PubMedGoogle Scholar
  27. 27.
    Bonten M, Kollef M, Hall J. Risk factors for ventilator-associated pneumonia: from epidemiology to patient management. Clin Infect Dis 2004;38:1141–1149.PubMedCrossRefGoogle Scholar
  28. 28.
    Beck-Sague C, Sinkowitz R, Chinn R, et al. Risk factors for ventilator-associated pneumonia in surgical intensive care-unit patients. Infect Control Hosp Epidemiol 1994;17:374–376.Google Scholar
  29. 29.
    Craven D, Kunches L, Kilinsky V, et al. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 1986;133:792–796.PubMedGoogle Scholar
  30. 30.
    Torres A, Gatell J, Aznar E, et al. Re-intubation increases the risk of nosocomial pneumonia in patients needing mechanical ventilation. Am J Respir Crit Care Med 1995;152:137–141.PubMedGoogle Scholar
  31. 31.
    Rello J, Sonora R, Jubert P, et al. Pneumonia in intubated patients: role of respiratory airway care. Am J Respir Crit Care Med 1996;154:111–115.PubMedGoogle Scholar
  32. 32.
    Donskey C. The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin Infect Dis 2004;39:219–226.PubMedCrossRefGoogle Scholar
  33. 33.
    Vollaard E, Clasener H. Colonization resistance. Antimicrob Agents Chemother 1994;38:409–414.PubMedGoogle Scholar
  34. 34.
    Hendrix C, Hammond J, Swoboda S, et al. Surveillance strategies and impact of vancomycin-resistant enterococcal (VRE) colonization and infection in critically ill patients. Ann Surg 2001;233:259–265.PubMedCrossRefGoogle Scholar
  35. 35.
    Pelz R, Lipsett P, Swoboda SM, et al. The diagnostic value of fungal surveillance cultures in critically ill patients. Surg Infect 2000;1:273–281.CrossRefGoogle Scholar
  36. 36.
    Ray A, Pultz N, Bhalla A, et al. Coexistence of vancomycin-resistant Entewcoccus and Staphylococcus aureus in the intestinal tracts of hospitalized patients. Clin Infect Dis 2003;37:875–881.PubMedCrossRefGoogle Scholar
  37. 37.
    Cunningham R, Dale B, Undy B, Gaunt N. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect 2003;54:243–245.PubMedCrossRefGoogle Scholar
  38. 38.
    Estes R, Meduri G. The pathogenesis of ventilator-associated pneumonia, 1: mechanisms of bacterial transcolonization and airway inoculation. Intensive Care Med 1995;21:365–383.PubMedCrossRefGoogle Scholar
  39. 39.
    Livrelli V, De Champs C, Di Martino P, et al. Adhesive properties and antibiotic resistance of Klebsiella, Enterobacter, and Serratia clinical isolates involved in nosocomial infections. J Clin Microbiol 1996;34:1963–1969.PubMedGoogle Scholar
  40. 40.
    Wang J, Chang S, Ko W, et al. A hospital-acquired outbreak of methicillin-resistant Staphylococcus aureus infection initiated by a surgeon carrier. J Hosp Infect 2001;47:104–109.PubMedCrossRefGoogle Scholar
  41. 41.
    Pettinger A, Nettleman M. Epidemiology of isolation precautions. Infect Control Hosp Epidemiol 1991;12:303–307.PubMedGoogle Scholar
  42. 42.
    Pittet D. Improving adherence to hand hygiene practice: a multidisciplinary approach. Emerg Infect Dis 2001;7:225–240.Google Scholar
  43. 43.
    Lipsett P, Swoboda S. Handwashing compliance depends on professional status. Surg Infect 2001;2:241–245.CrossRefGoogle Scholar
  44. 44.
    Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet 2000;356:1307–1290.PubMedCrossRefGoogle Scholar
  45. 45.
    Pittet D, Mourouga P, Perneger T, et al. Compliance with handwashing in a teaching hospital. Ann Intern Med 1999;130:126–130.PubMedGoogle Scholar
  46. 46.
    Swoboda S, Earsing K, Strauss K, et al. Electronic monitoring and voice prompts improve hand hygiene and decrease nosocomial infections in an intermediate care unit. Crit Care Med 2004;32:358–363.PubMedCrossRefGoogle Scholar
  47. 47.
    Streit J, Jones R, Sader H, et al. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). Int J Antimicrob Agents 2004;24:111–118.PubMedCrossRefGoogle Scholar
  48. 48.
    Emori T, Edwards J, Culver D, et al. Accuracy of reporting nosocomial infections in intensive care unit patients to the National Nosocomial Infections Surveillance (NNIS) system: a pilot study. Infect Control Hosp Epidemiol 1998;19:308–316.PubMedGoogle Scholar
  49. 49.
    Jarvis W. Benchmarking for prevention: the Centers for Disease Control and Prevention’s National Nosocomial Infections Surveillance (NNIS) system experience. Infection 2003;suppl 2:44–48.Google Scholar
  50. 50.
    Kaoutar B, Joly C, L’Heriteau F, et al. Nosocomial infections and hospital mortality: a multicenter epidemiological study. J Hosp Infect 2003;58:269–272.Google Scholar
  51. 51.
    The American Thoracic Society and Infectious Disease Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388–416.CrossRefGoogle Scholar
  52. 52.
    Kollef M. Prevention of hospital-associated pneumonia and ventilator-associated pneumonia. Crit Care Med 2004;32:1396–1405.PubMedCrossRefGoogle Scholar
  53. 53.
    Kollef M. Epidemiology and risk factors for nosocomial pneumonia. Emphasis on prevention. Clin Chest Med 1999;20:653–670.PubMedCrossRefGoogle Scholar
  54. 54.
    Kollef M. The prevention of ventilator-associated pneumonia. N Engl J Med 1999;340:627–634.PubMedCrossRefGoogle Scholar
  55. 55.
    Zack J, Garrison T, Trovillion E, et al. Effect of an education program aimed at reducing the occurrence of ventilator-associated pneumonia. Crit Care Med 2002;30:2407–2412.PubMedCrossRefGoogle Scholar
  56. 56.
    Cook D, Kollef M. Risk factors for ICU-acquired pneumonia. JAMA 1998;279:1605–1606.PubMedCrossRefGoogle Scholar
  57. 57.
    Messori A, Trippoli S, Vaiani M, et al. Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials. BMJ 2000;321:1103–1106.PubMedCrossRefGoogle Scholar
  58. 58.
    Ben-Menachem T, Fogel R, Patel R, et al. Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit. A randomized, controlled, single-blind study. Ann Intern Med 1994;121:568–575.PubMedGoogle Scholar
  59. 59.
    Eddleston J, Pearson R, Holland J, et al. Prospective endoscopic study of stress erosions and ulcers in critically ill adult patients treated with either sucralfate or placebo. Crit Care Med 1994;22:1949–1954.PubMedGoogle Scholar
  60. 60.
    Cook D, Guyatt G, Marshall J, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med 1998;338:791–797.PubMedCrossRefGoogle Scholar
  61. 61.
    Bonten M, Bergmans D, Ambergen A, et al. Risk factors for pneumonia, and colonization of respiratory tract and stomach in mechanically ventilated ICU patients. Am J Respir Crit Care Med 1996;154:1339–1346.PubMedGoogle Scholar
  62. 62.
    Garrouste-Oregas M, Chevret S, Arlet G, et al. Oropharyngeal or gastric colonization and nosocomial pneumonia in adult intensive care unit patients: a prospective study based on genomic DNA analysis. Am J Respir Crit Care Med 1997;156:1647–1655.Google Scholar
  63. 63.
    Heyland D, Drover J, Dhaliwal R, Greenwood J. Optimizing the benefits and minimizing the risks of enteral nutrition in the critically ill: role of small bowel feeding. JPEN J Parenter Enteral Nutr 2002;26:S51–S55.PubMedCrossRefGoogle Scholar
  64. 64.
    Dodek P, Keenan S, Cook D, et al. Evidenced-based clinical practice guideline for the prevention of ventilator-associated pneumonia. Ann Intern Med 2004;141:305–313.PubMedGoogle Scholar
  65. 65.
    Drakulovic M, Torres A, Bauer T, et al. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet 1999;354:1851–1858.PubMedCrossRefGoogle Scholar
  66. 66.
    Cook D, Walter S, Cook R, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998;129:433–440.PubMedGoogle Scholar
  67. 67.
    Hernandez G, Rico P, Diaz E, et al. Nosocomial lung infections in adult intensive care units. Microbes Infect 2004;6:1004–1014.PubMedCrossRefGoogle Scholar
  68. 68.
    Marik P, Careau P. The role of anaerobes in patients with ventilator-associated pneumonia, and aspiration pneumonia: a prospective study. Chest 1999;115:178–183.PubMedCrossRefGoogle Scholar
  69. 69.
    Hubmair. R. Statement of the Fourth International Consensus Conference in Critical Care on ICU-Acquired Pneumonia, Chicago, IL, May 2002. Intensive Care Med 2002;28:1521–1536.CrossRefGoogle Scholar
  70. 70.
    Michaud S, Suzuki S, Harbath S. Effect of design-related bias in studies of diagnostic tests for ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;166:1320–1325.PubMedCrossRefGoogle Scholar
  71. 71.
    Waterer G, Wunderink R. Controversies in the diagnosis of ventilator-associated pneumonia. Med Clin North Am 2001;85:1565–1581.PubMedCrossRefGoogle Scholar
  72. 72.
    Mehta R, Niederman M. Nosocomial pneumonia in the intensive care unit: controversies and dilemmas. J Intensive Care Med 2003;18:175–188.PubMedCrossRefGoogle Scholar
  73. 73.
    Fagon J, Chastre J, Wolff M, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: a randomized trial. Ann Intern Med 2000;132:621–630.PubMedGoogle Scholar
  74. 74.
    Sole Violan J, Fernandez J, Benitez A, et al. Impact of quantitative invasive diagnostic techniques in the management and outcome of mechanically ventilated patients with suspected pneumonia. Crit Care Med 2000;28:2737–2741.PubMedCrossRefGoogle Scholar
  75. 75.
    Baughman R, Thorpe J, Staneck J, et al. Use of the protected specimen brush in patients with endotracheal or tracheostomy tubes. Chest 1987;91:233–236.PubMedCrossRefGoogle Scholar
  76. 76.
    Chastre J, Fagon J, Soler P, et al. Diagnosis of nosocomial bacterial pneumonia in intubated patients undergoing ventilation: comparison of the usefulness of bronchoalveolar lavage and the protected specimen brush. Am J Med 1988;85:499–450.PubMedGoogle Scholar
  77. 77.
    Fagon J. Hospital-acquired pneumonia: diagnostic strategies: lessons from clinical trials. Infect Dis Clin N Am 2003:17;717–726.CrossRefGoogle Scholar
  78. 78.
    Pugin J, Auckenthaler R, Mili N, et al. Diagnosis of ventilator associated pneumonia by bacteriologic analysis of bronchoscope and nonbronchoscopic “blind” bronchoalveolar lavage fluid. Am Rev Respir Dis 1991;143:1121–1129.PubMedGoogle Scholar
  79. 79.
    Heyland D, Cook D, Marshall J, et al. The clinical utility of invasive diagnostic techniques in the setting of ventilator-associated pneumonia. Canadian Critical Care Trials Group. Chest 1999;115:1076–1084.PubMedCrossRefGoogle Scholar
  80. 80.
    Sanchez-Nieto J, Torres A, Garcia-Cordoba F, et al. Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study. Am J Respir Crit Care Med 1998;157:371–376.PubMedGoogle Scholar
  81. 81.
    Ruiz M, Torres A, Ewig S, et al. Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome. Am J Respir Crit Care Med 2000;162:119–125.PubMedGoogle Scholar
  82. 82.
    Pingleton S, Fagon J, Leeper K Jr. Patient selection for clinical investigation of ventilator-associated pneumonia: criteria for evaluating diagnostic techniques. Chest 1992;102:553S–556S.PubMedCrossRefGoogle Scholar
  83. 83.
    Meduri G, Chastre J. The standardization of bronchoscopic techniques for ventilator-associated pneumonia. Chest 1992;102:557S–564S.PubMedCrossRefGoogle Scholar
  84. 84.
    Shorr A, Sherner J, Jackson W, et al. Invasive approaches to the diagnosis of ventilator-associated pneumonia: a meta-analysis. Crit Care Med 2005;33:46–53.PubMedCrossRefGoogle Scholar
  85. 85.
    Singh N, Rogers P, Atwood C, et al. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: a proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000;162:505–511.PubMedGoogle Scholar
  86. 86.
    Sole-Violan J, Fernandez J, Benitez A, et al. Impact of quantitative invasive diagnostic techniques in the management and outcome of mechanically ventilated patients with suspected pneumonia. Crit Care Med 2000;28:2737–2741.PubMedCrossRefGoogle Scholar
  87. 87.
    Rello J, Paiva J, Baraibar K, et al. International Conference for the Development of the Consensus on the Diagnosis and Treatment of Ventilator-Associated Pneumonia. Chest 2001;120:955–970.PubMedCrossRefGoogle Scholar
  88. 88.
    Luna C, Vujacich P, Niederman M, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997;111:676–685.PubMedCrossRefGoogle Scholar
  89. 89.
    Ibrahim E, Ward S, Sherman G, et al. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 2001;29:1109–1115.PubMedCrossRefGoogle Scholar
  90. 90.
    Micek S, Ward S, Fraser V, et al. A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest 2004;125:1791–1799.PubMedCrossRefGoogle Scholar
  91. 91.
    Wunderink R, Cammarata S, Oliphant T, et al. Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia. Clin Ther 2003;25:980–992.PubMedCrossRefGoogle Scholar
  92. 92.
    Rubinstein E, Cammarata S, Oliphant T, et al. Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. Clin Infect Dis 2001;32:402–412.PubMedCrossRefGoogle Scholar
  93. 93.
    Heyland D, Cook D, Griffith L, et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999;159:1249–1256.PubMedGoogle Scholar
  94. 94.
    Fagon J, Chastre J, Hance A, et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993;94:281–288.PubMedCrossRefGoogle Scholar
  95. 95.
    Baker A, Meredith J, Haponik E. Pneumonia in intubated trauma patients. Microbiology and outcomes. Am J Respir Crit Care Med 1996;153:343–349.PubMedGoogle Scholar
  96. 96.
    Cunnion K, Weber D, Broadhead W, et al. Risk factors for nosocomial pneumonia: comparing adult critical-care populations. Am J Respir Crit Care Med 1996;153:158–162.PubMedGoogle Scholar
  97. 97.
    Craig C, Connelly S. Effect of intensive care unit nosocomial pneumonia on duration of stay and mortality. Am J Infect Control 1984;12:233–238.PubMedCrossRefGoogle Scholar
  98. 98.
    Kappstein I, Schulgen G, Beyer U, et al. Prolongation of hospital stay and extra costs due to ventilator-associated pneumonia in an intensive care unit. Eur J Clin Microbiol Infect Dis 1992;11:504–508.PubMedCrossRefGoogle Scholar
  99. 99.
    Papazian L, Bregeon F, Thirion X, et al. Effect of ventilator-associated pneumonia on mortality and morbidity. Am J Respir Crit Care Med 1996;154:91–97.PubMedGoogle Scholar
  100. 100.
    Pittet D, Tarara D, Wenzel R. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994;271:1598–1601.PubMedCrossRefGoogle Scholar
  101. 101.
    Heyland D, Cook D, Griffith L, et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999;159:1249–1256.PubMedGoogle Scholar
  102. 102.
    Dimick J, Pelz R, Consunji R, et al. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg 2001;136:229–234.PubMedCrossRefGoogle Scholar
  103. 103.
    Harbath S, Garbino J, Pugin J, et al. Inappropriate initial antibiotic therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003;115:529–535.CrossRefGoogle Scholar
  104. 104.
    Farr B. Prevention and control of methicillin-resistant Staphylococcus aureus infections. Curr Opin Infect Dis 2004;17:317–322.PubMedCrossRefGoogle Scholar
  105. 105.
    Garner J, Jarvis W, Emori T, et al. CDC definitions for nosocomial infections. Am J Infect Control 1988;16:128–140.PubMedCrossRefGoogle Scholar
  106. 106.
    O’Grady N, Alexander M, Dellinger E, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 2002;51:1–29.Google Scholar
  107. 107.
    Wisplinghoff H, Bischoff T, Tallent S, et al. Nosocomial bloodstream infections in U.S. hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004;39:309–317.PubMedCrossRefGoogle Scholar
  108. 108.
    Mermel L, Farr B, Sherertz R, et al. Infectious Diseases Society of America, American College of Critical Care Medicine, and Society for Healthcare Epidemiology of America. Guidelines for the management of intravascular catheter related infections. Clin Infect Dis 2001;32:1249–1272.PubMedCrossRefGoogle Scholar
  109. 109.
    Cobb D, High K, Sawyer R, et al. A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. N Engl J Med 1992;327:1062–1068.PubMedGoogle Scholar
  110. 110.
    Raad I, Hohn D, Gilbreath B, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994;15:231–238.PubMedGoogle Scholar
  111. 111.
    Maki D, Ringer M, Alvarado C. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991;338:339–343.PubMedCrossRefGoogle Scholar
  112. 112.
    Darouiche R, Raad I, Heard S, et al. A comparison of two antimicrobial-impregnated central venous catheters. N Engl J Med 1999;340:1–8.PubMedCrossRefGoogle Scholar
  113. 113.
    Veenstra D, Saint S, Sullivan S. Cost-effectiveness of antiseptic-impregnated central venous catheter for the prevention of catheter-related bloodstream infection. JAMA 1999;282:554–560.PubMedCrossRefGoogle Scholar
  114. 114.
    Veenstra D, Saint S, Saha S, et al. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection. A meta-analysis. JAMA 1999;281:261–267.PubMedCrossRefGoogle Scholar
  115. 115.
    Maki D, Stolz, S, Wheeler S, et al. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med 1997;127:257–266.PubMedGoogle Scholar
  116. 116.
    Raad I, Darouiche R, Dupuis J, et al. A central venous catheter coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. Ann Intern Med 1997;127:267–274.PubMedGoogle Scholar
  117. 117.
    Sherertz R, Ely E, Westbrook D, et al. Education of physicians-in-training can decrease the risk for vascular catheter infection. Ann Intern Med 2000;132:641–648.PubMedGoogle Scholar
  118. 118.
    Coopersmith C, Rebmann T, Zack J, et al. Effect of an education program on decreasing catheter-related bloodstream infections in the surgical intensive care unit. Crit Care Med 2002;30:59–64.PubMedCrossRefGoogle Scholar
  119. 119.
    Warren D, Zack J, Cox M, et al. An educational intervention to prevent catheter-associated bloodstream infections in a non-teaching, community medical center. Crit Care Med 2003;31:1959–1963.PubMedCrossRefGoogle Scholar
  120. 120.
    Warren J. Catheter-associated urinary tract infections. Int J Antimicrob Agents 2001;17:299–303.PubMedCrossRefGoogle Scholar
  121. 121.
    Stamm W. Catheter-associated urinary tract infections: epidemiology, pathogenesis, and prevention. Am J Med 1991;91:65S–71S.PubMedCrossRefGoogle Scholar
  122. 122.
    Haley R, Hooton T, Culver D, et al. Nosocomial infections in U.S. hospitals, 1975–1976: estimated frequency by selected characteristics of patients. Am J Med 1981;70:947–59.PubMedCrossRefGoogle Scholar
  123. 123.
    Saint S, Wiese J, Amory J, et al. Are physicians aware of which of their patients have indwelling urinary catheters? Am J Med 2000;109:476–480.PubMedCrossRefGoogle Scholar
  124. 124.
    Warren J. Catheter-associated urinary tract infections. Infect Dis Clin North Am 1997;11:609–622.PubMedCrossRefGoogle Scholar
  125. 125.
    Warren J, Piatt R, Thomas R, et al. Antibiotic irrigation and catheter-associated urinary-tract infections. N Engl J Med 1978;299:570–573.PubMedCrossRefGoogle Scholar
  126. 126.
    Saint S. Clinical and economic consequences of nosocomial catheter related bacteriuria. Am J Infect Control 2000;28:68–75.PubMedCrossRefGoogle Scholar
  127. 127.
    Silveira F, Fujitani S, Paterson D. Antibiotic-resistant infections in the critically ill adult. Clin Lab Med 2004;24:329–341.PubMedCrossRefGoogle Scholar
  128. 128.
    Wagenlehner F, Naber, K. Hospital-acquired urinary tract infections. J Hosp Infect 2000;46:171–181.PubMedGoogle Scholar
  129. 129.
    Tambyah P. Catheter-associated urinary tract infections: diagnosis and prophylaxis. Int J Antimicrob Agents 2004;24S;S44–S48.CrossRefGoogle Scholar
  130. 130.
    Tambyah P, Halvorson K, Maki D. A prospective study of the pathogenesis of catheter-associated urinary tract infection. Mayo Clin Proc 1999;74:131–136.PubMedCrossRefGoogle Scholar
  131. 131.
    Piatt R, Polk B, Murdock B, et al. Risk factors for nosocomial urinary tract infection. Am J Epidemiol 1986;124:977–985.Google Scholar
  132. 132.
    Johnson J, Roberts P, Olsen R, et al. Prevention of catheter-associated urinary tract infection with a silver oxide-coated urinary catheter: clinical and microbiologic correlates. J Infect Dis 1990;162:1145–1150.PubMedGoogle Scholar
  133. 133.
    Riley D, Classen D, Stevens L, et al. A large randomized clinical trial of a silver-impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. Am J Med 1995;98:349–356.PubMedCrossRefGoogle Scholar
  134. 134.
    Stark R, Maki D. Bacteriuria in the catheterized patient. What quantitative level of bacteriuria is relevant? N Engl J Med 1984;311:560–564.PubMedGoogle Scholar
  135. 135.
    Urinary Tract Infection (UTI) Working Group: Naber K, Bergman B, et al. EAU guidelines for the management of urinary and male genital tract infections. Eur Urol 2001;40:576–588.PubMedCrossRefGoogle Scholar
  136. 136.
    Tambyah P, Maki D. Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1497 catheterized patients. Arch Intern Med 2000;160:678–682.PubMedCrossRefGoogle Scholar
  137. 137.
    Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med 2002;113:14S–19S.PubMedCrossRefGoogle Scholar
  138. 138.
    Wagenlehner F, Naber K. New drugs for gram-positive uropathogens. Int J Antimicrob Agents 2004;24S:S39–S43.CrossRefGoogle Scholar
  139. 139.
    Carson C, Naber K. Role of fluroquinolones in the treatment of serious bacterial urinary infections. Drugs 2004;64:1359–1373.PubMedCrossRefGoogle Scholar
  140. 140.
    Talan D, Klimberg I, Nicolle L, et al. Once daily extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis. J Urol 2004;171:734–739.PubMedCrossRefGoogle Scholar
  141. 141.
    Maki D, Tambyah P. Engineering out the risk for infection with urinary catheters. Emerg Infect Dis 2001;7:342–347.PubMedGoogle Scholar
  142. 142.
    Ouslander J, Greengold B, Chen S. External catheter use and urinary tract infections among incontinent male nursing home patients. J Am Geriatr Soc 1987;35:1063–1070.PubMedGoogle Scholar
  143. 143.
    Huth T, Burke J, Larsen R, et al. Clinical trial of junction seals for the prevention of urinary catheter-associated bacteriuria. Arch Intern Med 1992;152:807–812.PubMedCrossRefGoogle Scholar
  144. 144.
    Kunin C, McCormack R. Prevention of catheter-induced urinary-tract infections by a new sterile closed drainage system. Antimicrobial Agents Chemother 1965;5:631–638.Google Scholar
  145. 145.
    Classen D, Larsen R, Burke J, et al. Prevention of catheter-associated bacteriuria: clinical trial of methods to block three known pathways of infection. Am J Infect Control 1991;19:136–142.PubMedCrossRefGoogle Scholar
  146. 146.
    Darouiche R, Smith J, Hanna H, et al. Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: a prospective, randomized, multicenter clinical trial. Urology 1999;54:976–981.PubMedCrossRefGoogle Scholar
  147. 147.
    Karchmer T, Giannetta E, Muto C, et al. A randomized crossover study of silver-coated urinary catheters in hospitalized patients. Arch Intern Med 2000;160:3294–3298.PubMedCrossRefGoogle Scholar
  148. 148.
    Johnson J, Roberts P, Olsen R, et al. Prevention of catheter-associated urinary tract infection with a silver oxide-coated urinary catheter: clinical and microbiologic correlates. J Infect Dis 1990;162:1145–1150.PubMedGoogle Scholar
  149. 149.
    Saint S, Elmore J, Sullivan S, et al. The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: a meta-analysis. Am J Med 1998;105:236–241.PubMedCrossRefGoogle Scholar
  150. 150.
    Karchmer T, Giannetta E, Muto C, et al. A randomized crossover study of silver-coated urinary catheters in hospitalized patients. Arch Intern Med 2000;160:3294–3298.PubMedCrossRefGoogle Scholar
  151. 151.
    Maki D, Knasinski V, Halvorson K, et al. A novel silver hydro-gel-impregnated indwelling urinary catheter reduces catheter related urinary tract infections: a prospective double-blind trial [abstract]. Infect Control Hosp Epidemiol 1998;19:682.Google Scholar
  152. 152.
    Thibon P, Le Coutour X, Leroyer R, et al. Randomized multicentre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital-acquired urinary tract infections. J Hosp Infect 2000;45:117–124.PubMedCrossRefGoogle Scholar
  153. 153.
    Verleyen P, De Ridder D, Van Poppel H, et al. Clinical application of the Bardex IC Foley catheter. Eur Urol 1999;36:240–246.PubMedCrossRefGoogle Scholar
  154. 154.
    Bologna R, Tu L, Polansky M, et al. Hydrogel/silver ion-coated urinary catheter reduces nosocomial urinary tract infection rates in intensive care unit patients: a multicenter study. Urology 1999;54:982–987.PubMedCrossRefGoogle Scholar
  155. 155.
    Gerding D, Johnson S, Peterson LR, et al. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995;16:459–477.PubMedGoogle Scholar
  156. 156.
    Archibald L, Banerjee S, Jarvis W. Secular trends in hospital-acquired C. difficile disease in the United States 1897–2001. J Infect Dis 2004;189:1585–1589.PubMedCrossRefGoogle Scholar
  157. 157.
    Oldfield E. Clostridium difficile-associated diarrhea: risk factors, diagnostic methods, and treatment. Rev Gastroenterol Disord 2004;4:186–195.PubMedGoogle Scholar
  158. 158.
    Bricker E, Garg R, Nelson R. Antibiotic treatment of Clostridium difficile-associated diarrhea in adults. Cochrane Database Syst Rev 2005,1CD 004610, pub2.Google Scholar
  159. 159.
    Vandenbussche T, De Moor S, Bachert C, et al. Value of antral puncture in the intensive care patient with fever of unknown origin. Laryngoscope 2000;110:1702–1706.PubMedCrossRefGoogle Scholar
  160. 160.
    LeMoal G, Lemerre D, Grollier G, et al. Nosocomial sinusitis with isolation of anaerobic bacteria in ICU patients. Intensive Care Med 1999;25:1066–1071.CrossRefGoogle Scholar
  161. 161.
    Merle V, Germain JM, Bugel H, et al. Nosocomial urinary tract infections in urologic patients: assessment of a prospective surveillance program including 10,000 patients. Eur Urol 2002;41:48–49.CrossRefGoogle Scholar
  162. 161.
    Jones RN, Kugler KC, Pfaller MA, et al. Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program 1997. Diagn Microbiol Infect Dis 1999;35:55–63.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Pamela A. Lipsett
    • 1
  1. 1.Department of Surgery, Anesthesiology/Critical Care MedicineJohns Hopkins University Schools of Medicine and NursingBaltimoreUSA

Personalised recommendations